Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cod protein is a high-quality, lean dietary protein derived from cod fish (Gadus morhua), available both from fish fillets and from residual materials like backbones and skin. It is being investigated as a dietary supplement and nutraceutical for its potential metabolic health benefits. Clinical and preclinical studies have explored its role in managing conditions related to obesity. Research suggests that supplementation with cod protein may improve insulin sensitivity, reduce postprandial glucose concentrations, lower circulating levels of nonesterified fatty acids, and exert anti-inflammatory effects, such as reducing C-reactive protein. [8] Some studies indicate these effects may be mediated by normalizing insulin signaling pathways (like PI 3-kinase/Akt) in skeletal muscle and increasing levels of the hormone adiponectin. [2, 6] It is typically administered orally in tablet or powder form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cod protein.